CLB vs XOM vs JPM

For growth investors, JPMorgan Chase & Co.

(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -4. 5% for Exxon Mobil Corporation (XOM). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 9x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 15. 9x versus Exxon Mobil Corporation at 21. 0x. On forward P/E, Exxon Mobil Corporation is actually cheaper at 12. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +148.

5%, compared to -71. 5% for Core Laboratories N. V. (CLB). Over 10 years, the gap is even starker: JPM returned +475. 6% versus CLB's -83. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.

37β versus Core Laboratories N. V. 's 0. 96β — meaning CLB is approximately -357% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), JPMorgan Chase & Co.

(JPM) is pulling ahead at 3. 3% versus -4. 5% for Exxon Mobil Corporation (XOM). On earnings-per-share growth, the picture is similar: Core Laboratories N. V. grew EPS 3. 0% year-over-year, compared to -14. 5% for Exxon Mobil Corporation. Over a 3-year CAGR, CLB leads at 2. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus 6. 0% for Core Laboratories N. V. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 9. 3% for CLB. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Exxon Mobil Corporation (XOM) trades at 12.

9x forward P/E versus 21. 2x for Core Laboratories N. V. — 8. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLB: 96. 5% to $25. 00.

All stocks in this comparison pay dividends.

Exxon Mobil Corporation (XOM) offers the highest yield at 2. 8%, versus 0. 3% for Core Laboratories N. V. (CLB).

For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

37), 2. 8% yield). Both have compounded well over 10 years (XOM: +95. 6%, CLB: -83. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CLB (Energy) and XOM (Energy) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CLB is a small-cap quality compounder stock; XOM is a large-cap quality compounder stock; JPM is a large-cap deep-value stock. XOM, JPM pay a dividend while CLB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.